Status:
TERMINATED
Optical Coherence Tomography of Retinal Abnormalities Associated With Choroidal Nevus, Choroidal Melanoma and Choroidal Melanoma Treated With Iodine-125 Brachytherapy
Lead Sponsor:
Jonsson Comprehensive Cancer Center
Conditions:
Ocular Melanoma
Eligibility:
All Genders
18+ years
Brief Summary
During regularly scheduled appointments, Optical Coherence Tomography (OCT) is performed on consented subjects. The OCT is a new type of camera that takes very detailed pictures inside of the eye and ...
Eligibility Criteria
Inclusion
- Adults (18 years or older) with:
- choroidal nevus greater than or equal to 3.0 mm in longest basal diameter, or greater than or equal to 1.25 mm in apical height or:
- choroidal melanoma located in the posterior pole (4mm or less from the center of fovea or the border of the optic nerve head)
Exclusion
- Ocular media opacity in the tumor eye that prevents adequate functional testing or imaging and prior or concurrent retinal or choroidal disease in the tumor eye that prevents adequate functional testing or imaging
Key Trial Info
Start Date :
March 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 27 2017
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT00346372
Start Date
March 1 2004
End Date
November 27 2017
Last Update
August 12 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jules Stein Eye Institute
Los Angeles, California, United States, 90095